N/A
Completed N=2,196
Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179)
Source: ClinicalTrials.gov NCT01436253 ↗Enrolled (actual)
2,196
Serious AEs
0.0%
Results posted
Jan 2014
Primary outcomePrimary: Percentage of Participants Achieving Target Lipid Values — 46.8 Percentage of participants
Summary
This study is being done to see whether dietary and medicinal measures compliant with hyperlipidemia treatment guidelines will result in achieving target lipid values and to evaluate the total risk of cardiovascular disease in study participants who have not reached satisfactory lipid levels with their current hypolipemic therapy.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants Achieving Target Lipid Values |
46.8 | — |
| PRIMARY Percentage of Participants With Reduced Cardiovascular Risk |
51.1 | — |
Eligibility Criteria
Inclusion criteria
- Hyperlipidemic
- On therapy for hyperlipidemia for >=3 months without achieving target lipid values
Exclusion criteria
- Hypersensitivity or intolerance to hypolipemics
- Significant myopathy or rhabdomiolysis probably caused by hypolipemics
- Uncontrolled endocrine or metabolic disease which is known to affect lipid or lipoprotein values (for example, hypothyroidism and hyperthyroidism)
Data sourced from ClinicalTrials.gov (NCT01436253). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.